This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 16:03, 11 February 2011 (Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_Pharmacology|errors). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 16:03, 11 February 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_Pharmacology|errors)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundIdentifiers | |
---|---|
IUPAC name
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H21NO |
Molar mass | 231.333 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
α-Pyrrolidinopentiophenone or α-PVP is a stimulant compound developed in the 1960s and related to pyrovalerone, which has been reported as a novel designer drug.
See also
References
- Ernst Seeger. α-Pyrrolidinyl ketones. US Patent 3314970
- Sauer C, Peters FT, Haas C, Meyer MR, Fritschi G, Maurer HH. New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. Journal of Mass Spectrometry. 2009 Jun;44(6):952-64. PMID: 19241365
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |